Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.59 |
| ▸ | BACE1 | P56817 | 1/20 | 0.57 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.57 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | GLP1R | P43220 | 6/20 | 0.53 |
| ▸ | PTH1R | Q03431 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Magainin 2 SCHEMBL29357968 | 0.97 | CALCR (0.63) | CALCRBACE1CRHR1CRHR2RXFP1 | |
| SCHEMBL29633610 | 0.97 | CALCR (0.63) | CALCRBACE1CRHR1CRHR2RXFP1 | |
| SCHEMBL29949418 | 0.91 | CALCR (0.64) | CALCRBACE1CRHR1CRHR2RXFP1 | |
| SCHEMBL31438606 | 0.91 | TFPI (0.54) | CALCRGLP1R | |
| SCHEMBL30633102 | 0.91 | PTH1R (0.61) | BACE1RXFP1GLP1RPTH1R | |
| SCHEMBL30262006 | 0.89 | GLP1R (0.52) | CALCRCRHR1CRHR2RXFP1GLP1R | |
| SCHEMBL30262193 | 0.89 | PTH1R (0.64) | CALCRRXFP1KEAP1GLP1RPTH1R | |
| SCHEMBL30658366 | 0.89 | CALCR (0.60) | CALCRCRHR1CRHR2RXFP1KEAP1 | |
| SCHEMBL30432434 | 0.88 | CALCR (0.66) | CALCRBACE1CRHR1CRHR2GLP1R | |
| SCHEMBL30524353 | 0.87 | GLP1R (0.48) | CALCRRXFP1GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025018943-A1 | BIODEGRADABLE POLYION COMPLEX NANOPARTICLES OF CATIONIC ANTIMICROBIALS FOR ACTIVATABLE ANTIBACTERIAL THERAPY | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-01-23 | — | — | WO | claimed |
| US-11725227-B2 | Devices and methods for examining drug effects on microorganisms | ESSENLIX CORPORATION (US) | 2023-08-15 | — | — | US | claimed |
| CN-114748692-B | Mesoporous silica-based surface-functionalized titanium-based implant, and preparation method and application thereof | 华南理工大学 | 2023-06-20 | — | — | CN | claimed |
| CN-110927372-B | Colorimetric immunosensor based on double nano-composites and preparation method and application thereof | 军事科学院军事医学研究院军事兽医研究所 | 2022-12-06 | — | — | CN | claimed |
| CN-114748692-A | Surface functionalized titanium-based implant based on mesoporous silica and preparation method and application thereof | 华南理工大学 | 2022-07-15 | — | — | CN | claimed |
| CN-110531075-B | Pathogenic bacteria immunoassay biosensor based on antibacterial peptide-phosphate nano compound and preparation method and application thereof | 军事科学院军事医学研究院军事兽医研究所 | 2022-06-14 | — | — | CN | claimed |
| US-12577602-B2 | Compositions and methods for peptide production | BIOCATALYST LLC (US) | 2026-03-17 | — | — | US | disclosed |
| EP-3574909-B1 | POLYELECTROLYTE MULTILAYER COMPRISING SILVER FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | IMBED BIOSCIENCES INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250375394-A1 | METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES | ABBOTT NICHOLAS L (US) | 2025-12-11 | — | — | US | disclosed |
| EP-4626479-A1 | COMPOSITIONS AND METHODS FOR PROTEIN INTERNALIZATION | Lytica Therapeutics, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| US-RE50618-E1 | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same | PHARMAIN CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-12409247-B2 | Methods and compositions for wound healing | IMBED BIOSCIENCES INC. (US) | 2025-09-09 | — | — | US | disclosed |
| EP-3983428-A1 | DE NOVO DESIGN OF PHOSPHORYLATION INDUCIBLE PROTEIN SWITCHES (PHOSPHO-SWITCHES) | University of Washington (US) | 2022-04-20 | — | — | EP | disclosed |
| CN-114302895-A | Novel design of phosphorylation-induced protein switch (phosphate switch) | 华盛顿大学 | 2022-04-08 | — | — | CN | disclosed |
| WO-2022069996-A1 | BIODEGRADABLE POLYMER AND SOLVENT COMPOSITIONS AND SYSTEMS FOR EXTENDED STORAGE AND DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS | TOLMAR INTERNATIONAL LIMITED (IE) | 2022-04-07 | — | — | WO | disclosed |
| US-20220073565-A1 | DE NOVO DESIGN OF PROTEIN SWITCHES FOR TUNABLE CONTROL OF PROTEIN DEGRADATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-03-10 | — | — | US | disclosed |
| WO-2022048733-A1 | METHOD FOR PRODUCING MACROPOROUS SCAFFOLDS COMPOSED OF SILK AND CALCIUM PHOSPHATE | SPIBER TECHNOLOGIES AB (SE) | 2022-03-10 | — | — | WO | disclosed |
| CN-109655609-B | Platinum-nanoflower and preparation method and application thereof | 军事科学院军事医学研究院军事兽医研究所 | 2022-03-01 | — | — | CN | disclosed |
| CN-114053481-A | Preparation method of titanium-based bone dental implant material loaded with antibacterial polypeptide and antibacterial ions | 广东省华源康泰生物科技有限责任公司 | 2022-02-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577602-B2 | Compositions and methods for peptide production | LNPEP, CPN1, PRCP | CALCR 278/4885BACE1 153/4885CRHR1 405/4885 |
| US-20260000805-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | PCNA, ARG1, PLOD3 | CALCR 2540/4885BACE1 4523/4885CRHR1 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.